Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery (5)
182 Articles Available
5
8
Can't find what you're looking for? Try our
advanced search
.
Inhalation
GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
PAO-M05-18-NI-022
Next-Generation Manufacturing
Thinking a Generation Ahead: Biologics-Based Therapy
PAP-Q2-18-FA-002
Fast Track
Valneva Receives Fast Track Designation for Lyme Disease Vaccine
PAO-M05-18-NI-021
Drug Discovery
RNA-Modifying Proteins May Provide New Drug Targets
PAO-M05-18-NI-018
Treatment
New Single-Pill HIV Treatment Approved in Europe
PAO-M05-18-NI-015
Drug Development
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
PR-M05-18-NI-060
Drug Discovery
XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery
PR-M05-18-NI-041
Inflammatory Disease
Gilead Sciences and Verily Life Sciences LLC Enter Collaboration, Hope to Better Understand Inflammatory Diseases
PAO-M05-18-NI-002
Strategic Collaboration
United Neuroscience Ltd. and Boston University Lee Goldstein Laboratory Enter Collaboration, Targeting Treatment and Prevention of Chronic Traumatic Encephalopathy (CTE)
PAO-M04-18-NI-012
Approval
Fresenius Kabi Announces New Approval and Immediate Availability of Daptomycin for Injection
PR-M04-18-NI-58
Drug Discovery
"Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery
PR-M04-18-NI-38
Laboratory Testing
Creating Comprehensive Solutions through Laboratory Testing
PAP-Q1-18-CL-011
Innovation
LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion in Platinum-Sensitive Relapsed Ovarian Cancer
PR-M02-18-NI-100
Drug Development
Pfizer Announces Update on European Marketing Authorization Application for SUTENT® (sunitinib) in Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
PR-M02-18-NI-99
Oncology
Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™and BOSULIF®
PR-M02-18-NI-98
Clinical Data
Bayer Announces Publication of Larotrectinib Data in The New England Journal of Medicine
PR-M02-18-NI-97
Acquistion
Allergen Acquires Elastagen
PAO-M02-18-NI-012
FDA Approval
Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
PR-M02-18-NI-036
Joint Venture
DSM and Evonik Establish Veramaris Joint Venture
PR-M02-18-NI-024
Immuno-Oncology
Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
PR-M02-18-NI-020
Financing
Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
PR-M02-18-NI-015
Contract
Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®
PR-M02-18-NI-013
Oncology
Stand Up To Cancer Announces $11M Collaborative, Multi-Disciplinary Research Program
PR-M02-18-NI-010
Discovery
Scientists Discover How Gene Mutation Triggers Immune Disease
PR-M02-18-NI-008
«
5
8
»
.svg)